Annals of Epidemiology
Volume 9, Issue 5 , Pages 297-306 , July 1999

Lung Function, Respiratory Symptoms, and Mortality: Results from the Busselton Health Study

  • Matthew W Knuiman, PhD

      Affiliations

    • Department of Public Health, University of Western Australia, Nedlands, Western Australia, Australia
    • Corresponding Author InformationAddress correspondence to: Associate Professor M.W. Knuiman, Department of Public Health, University of Western Australia, Nedlands, WA 6907, Australia
    • ,
  • Alan L James, MD, MBBS

      Affiliations

    • Department of Pulmonary Physiology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
    • ,
  • Mark L Divitini, BAppSc

      Affiliations

    • Department of Public Health, University of Western Australia, Nedlands, Western Australia, Australia
    • ,
  • Gerard Ryan, MBBS

      Affiliations

    • Sir Charles Gairdner Hospital, Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
    • ,
  • Helen C Bartholomew, GradDipComp

      Affiliations

    • Department of Public Health, University of Western Australia, Nedlands, Western Australia, Australia
    • ,
  • A.W Musk, MD, MBBS

      Affiliations

    • Sir Charles Gairdner Hospital, Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.

Received 26 September 1997 ,Revised 18 November 1998 ,Accepted 1 December 1998.

References 

  1. Higgins MW, Keller JB. Predictors of Mortality in the Adult Population of Tecumseh. Arch Environ Health. 1970;21:418–424
  2. Kannel WB, Hubert H, Lew EA. Vital Capacity as a Predictor of Cardiovascular Disease (The Framingham Study). Am Heart J. 1983;105:311–315
  3. Beaty TH, Cohen BH, Newell CA, Menkes HA, Diamond EL, Chen CJ. Impaired Pulmonary Function as a Risk Factor for Mortality. Am J Epidemiol. 1982;116:102–113
  4. Cullen K, Stenhouse NS, Wearne KL, Welborn TA. Multiple Regression Analysis of Risk Factors for Cardiovascular Disease and Cancer Mortality in Busselton, Western Australia (13-Year Study). J Chron Dis. 1983;36:371–377
  5. Peto R, Speizer FE, Cochrane AL, Moore F, Fletcher CM, Tinker CM, et al. The Relevance in Adults of Air Flow Obstruction, but not of Mucus Hypersecretion, to Mortality from Chronic Lung Disease. Results from 20 Years of Prospective Observation. Am Rev Respir Dis. 1983;128:491–500
  6. Krzyanowski M, Wysocki M. The relation of 13-Year Mortality to Ventilatory Impairment and Other Respiratory Symptoms (The Cracow Study). Int J Epidemiol. 1986;15:56–64
  7. Vollmer WM, McCamant LE, Johnson LR, Buist AS. Respiratory Symptoms, Lung Function, and Mortality in a Screening Center Cohort. Am J Epidemiol. 1989;129:1157–1169
  8. Ebi-Kryston KL, Hawthorne VM, Rose G, Shipley MJ, Gillis CR, Hole DJ, et al. Breathlessness, Chronic Bronchitis, and Reduced Pulmonary Function as Predictors of Cardiovascular Disease Mortality among Men in England, Scotland, and the United States. Int J Epidemiol. 1989;18:84–88
  9. Ebi-Kryston KL. Predicting 15-Year Chronic Bronchitis Mortality in the Whitehall Study. J Epidemiol Comm Health. 1989;43:168–172
  10. Marcus EB, Curb JD, MacLean CJ, Reed DM, Yano K. Pulmonary Function as a Predictor of Coronary Heart Disease. Am J Epidemiol. 1989;129:97–104
  11. Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P. Relation of Ventilatory Impairment and of Chronic Mucus Hypersecretion to Mortality from Obstructive Lung Disease and from All Causes. Thorax. 1990;45:579–585
  12. Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P. Spirometric Fndings and Mortality in Never Smokers. J Clin Epidemiol. 1990;43:867–873
  13. Kuller LH, Ockene J, Meilahn E, Svendsen KH for the Multiple Risk Factor Intervention Trial Research Group . Relation of Forced Expiratory Volume in One Second (FEV1) to Lung Cancer Mortality in the Multiple Risk Factor Intervention Trail (MRFIT). Am J Epidemiol. 1990;132:265–274
  14. Strachan DP. Ventilatory Function as a Predictor of Fatal Stroke. BMJ. 1991;302:84–87
  15. Van den Eeden SK, Friedman GD. Forced Expiratory Volume (1 Second) and Lung Cancer Incidence and Mortality. Epidemiology. 1992;3:253–257
  16. Bang KM, Gergen PJ, Kramer R, Cohen B. The Effect of Pulmonary Impairment on All Cause Mortality in a National Cohort. Chest. 1993;103:536–540
  17. Hole DJ, Watt GC, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM. Impaired Lung Function and Mortality Risk in Men and Women (Findings from the Renfrew and Paisley Prospective Study). BMJ. 1996;313:711–715
  18. Welborn TA. The Busselton Study (Mapping Population Health. Cardiovascular and Respiratory Disease Risk Factors in Busselton, Australia). Sydney, Australia: Australasian Medical Publishing Company; 1998;
  19. Cullen KJ. Mass Health Examinations in the Busselton Population, 1966 to 1970. Med J Aust. 1972;2:714–718
  20. Webster IW. Busselton, A Community Study in Cardiovascular Disease. Aust NZ J Med. 1974;4:412–414
  21. Knuiman MW, Cullen KJ, Bulsara MK, Welborn TA, Hobbs MST. Mortality Trends, 1965 to 1989, in Busselton, the Site of Repeated Health Surveys and Interventions. Aust J Publ Health. 1994;18:129–135
  22. Knuiman MW, Jamrozik K, Welborn TA, Bulsara MK, Divitini ML, Whittall DE. Age and Secular Trends in Risk Factors for Cardiovascular Disease in Busselton. Aust J Publ Health. 1995;19:375–382
  23. Medical Research Council . Questionnaire on Respiratory Symptoms and Instructions for Its Use. London: Medical Research Council; 1966;
  24. Welborn TA, Cumptson GN, Cullen KJ, Curnow DH, McCall MG, Stenhouse NS. The Prevalence of Coronary Heart Disease and Associated Factors in an Australian Rural Community. Am J Epidemiol. 1969;89:521–536
  25. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York: Wiley; 1980;
  26. SAS/STAT Software. Changes and Enhancements through Release 6.11. Carey, North Carolina: SAS Institute, Inc. 1996.
  27. Strachan DP. Ventilatory Function, Height, and Mortality among Life-Long Nonsmokers. J Epidemiol Comm Health. 1992;46:66–70
  28. Curb JD, Marcus EB, Reed DM, MacLean C, Yano K. Smoking, Pulmonary Function, and Mortality. Ann Epidemiol. 1990;1:25–32
  29. Lange P, Nyboe J, Jensen G, Schnohr P, Appleyard M. Ventilatory Function Impairment and Risk of Cardiovascular Death and of Fatal or Nonfatal Myocardial Infarction. Eur Respir. 1991;4:1080–1087
  30. Higgins MW, Keller JB. Seven Measures of Ventilatory Lung Function. Am Rev Resp Dis. 1973;108:258–272
  31. Simons LA, McCallum J, Simons J, Friedlander Y. Relationship of Peak Expiratory Flow Rate with Mortality and Ischemic Heart Disease in Elderly Australians. Med J Aust. 1997;166:526–529
  32. Cook NR, Hebert PR, Satterfield S, Taylor JO, Buring JE, Hennekens CH. Height, Lung Function, and Mortality from Cardiovascular Disease among the Elderly. Amer J Epidemiol. 1994;139:1066–1076
  33. Higgins M, Keller JB, Wagenknecht LE, Townsend MC, Sparrow D, Jacobs DR, et al. Pulmonary Function and Cardiovascular Risk Factor Relationships in Black and White Men and Women. The Cardia Study. Chest. 1991;99:315–322
  34. Kannel WB, Seidman JM, Fercho MS. Vital Capacity and Congestive Heart Failure (The Framingham Study). Circulation. 1974;49:1160–1166
  35. Kales A, Bixler EO, Cadieux RJ, Schneck DW, Shaw LC, Locke TW, et al. Sleep Apnea in a Hypertensive Population. Lancet. 1984;2:1005–1008
  36. Sorlie PD, Kannel WB, O’Connor G. Mortality Associated with Respiratory Function and Symptoms in Advanced Age. Am Rev Respir Dis. 1989;140:379–384

PII: S1047-2797(98)00066-0

Annals of Epidemiology
Volume 9, Issue 5 , Pages 297-306 , July 1999

Article Tools